Contact Details
Matt Riley - Head of Investor Relations & Corporate Communications
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
October 21, 2022 at 11:00 AM EDT
More NewsView More
Lululemon Slips as Rivals Rally: 3 Stocks to Watch
June 30, 2025
The Top Insider Sells From Q2: Buy, Sell, or Hold?
June 30, 2025
Why BigBear.ai Could Rally 100% and Catch Palantir Soon
June 30, 2025
5 High-Yielding ETFs to Buy and Hold Forever
June 30, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|
